ArticleScientific reports2025

Pharmacovigilance analysis of neurological adverse events associated with GLP-1 receptor agonists based on the FDA Adverse Event Reporting System.

He Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.